Published in Br J Clin Pharmacol on January 01, 1982
Retinal changes in malignant hypertension. Br Med J (Clin Res Ed) (1986) 0.87
Benefits from treatment and control of patients with resistant hypertension. Int J Hypertens (2010) 0.82
"Hypertensive emergency": a useful diagnostic category. Am J Public Health (1988) 0.77
Screening for hypertension: some epidemiological observations. Br Med J (1974) 4.22
The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med (1958) 4.20
Results of treatment in malignant hypertension: a seven-year experience in 94 cases. Br Med J (1959) 3.81
Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med (1980) 3.19
Natural history of hypertension. A case for selective non-treatment. Lancet (1974) 2.97
Prognosis of vascular hypertension; a 9 year follow-up study of 418 cases. Arch Intern Med (Chic) (1950) 1.85
The natural history and course of hypertension with papilledema (malignant hypertension). Am Heart J (1953) 1.83
Some aspects of prognosis in treated hypertension. Br Med J (1959) 1.78
Five-year mortality in the city of Bergen, Norway, according to age, sex and blood pressure. Acta Med Scand (1976) 1.60
Basal and supplemental blood pressures in relationship to life expectancy and hypertension symptomatology. N Z Med J (1959) 1.34
Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA (1966) 1.21
Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project. Lancet (1979) 1.17
Five year follow-up of effects of treatment of mild and moderate hypertension. Br Med J (Clin Res Ed) (1981) 1.04
Antihypertensive therapy in patients above age 60 years (Fourth Interim report of the European Working Party on High Blood pressure in Elderly: EWPHE). Clin Sci Mol Med Suppl (1978) 0.87
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med (1999) 3.43
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Confidence intervals. Lancet (1987) 2.21
Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med (1992) 2.17
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Area deprivation, social class, and quality of life among people aged 75 years and over in Britain. Int J Epidemiol (2005) 1.79
Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol (1990) 1.76
How far should blood pressure be lowered? N Engl J Med (1992) 1.76
The drug treatment of hypertension. Practitioner (1971) 1.75
The retinal blood flow in diabetes. Diabetologia (1975) 1.72
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) (1985) 1.67
The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848]. BMC Health Serv Res (2002) 1.67
How obstetricians manage hypertension in pregnancy. Br Med J (1978) 1.56
Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension (1992) 1.53
The prognosis of falls in elderly people living at home. Age Ageing (1999) 1.52
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Prognosis in adult asthma: a national study. Br Med J (Clin Res Ed) (1987) 1.49
Vitamin C and blood pressure. J Hypertens (1990) 1.46
Blood pressure measurement in patients with rate controlled atrial fibrillation using mercury sphygmomanometer and Omron HEM-750CP deice in the clinic setting. J Hum Hypertens (2006) 1.45
Trial of combination of guanethidine and oxprenolol in hypertension. Br Med J (1976) 1.44
Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP) J Hum Hypertens (2000) 1.44
Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens (1988) 1.39
Analgesia and satisfaction in childbirth (the Queen Charlotte's 1000 Mother Survey). Lancet (1982) 1.39
Controlling hypertension in the elderly. QJM (2000) 1.37
Side effects of therapy in diabetes evaluated by a self-administered questionnaire. J Chronic Dis (1977) 1.35
Selective recording in blood pressure readings may increase subsequent mortality. QJM (2002) 1.33
Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol (1980) 1.32
The consumers' attitude to obstetric care. Br J Obstet Gynaecol (1984) 1.27
Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J (1976) 1.26
The effect of withdrawing antihypertensive therapy: a review. J Hypertens (1988) 1.23
Joint pain and quality of life; results of a randomised trial. Br J Clin Pharmacol (1989) 1.22
Urinary cadmium and lead concentrations and their relation to blood pressure in a population with low exposure. Br J Ind Med (1984) 1.20
Intraocular pressure and systemic blood pressure in the elderly. Br J Ophthalmol (1975) 1.20
Initial care of hypertensive patients. Influence of different types of clinical records. Br Heart J (1977) 1.18
Hydralazine, antinuclear antibodies, and the lupus syndrome. Br Med J (Clin Res Ed) (1982) 1.17
Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project. Lancet (1979) 1.17
Community care compared with hospital outpatient care for hypertensive patients. Br Med J (Clin Res Ed) (1982) 1.17
Factors influencing the incidence of neonatal jaundice. Br Med J (1978) 1.15
Environmental factors affecting antipyrine metabolism in London factory and office workers. Br J Clin Pharmacol (1979) 1.14
Visit frequency for essential hypertension: observed associations. J Fam Pract (1989) 1.13
Effect of changes in intraocular pressure on the retinal microcirculation. Br J Ophthalmol (1974) 1.13
The influence of menopause on blood pressure. J Hum Hypertens (1989) 1.13
Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol (1981) 1.12
The relationship between both sodium and potassium intake and blood pressure in London Civil Servants. A report from the Whitehall Department of Environment Study. J Chronic Dis (1986) 1.12
Streptokinase in the treatment of central retinal vein occlusion. A controlled trial. Trans Ophthalmol Soc U K (1974) 1.11
Stroke death and unemployment in London. J Epidemiol Community Health (1991) 1.10
Cotton-wool spots in diabetic retinopathy. Diabetes (1969) 1.09
Eye symptoms in patients taking propranolol and other hypotensive agents. Br J Clin Pharmacol (1977) 1.08
Factors affecting antipyrine metabolism in West African villagers. Clin Pharmacol Ther (1976) 1.08
Retinal and conjunctival haemorrhage in the newborn. Arch Dis Child (1970) 1.07
The marginal plasma zone in the retinal microcirculation. Cardiovasc Res (1970) 1.06
Retinal photography in the newborn. Arch Dis Child (1969) 1.06
Comparison of black and white patients attending hypertension clinics in England. Br Med J (1979) 1.05
A comparison of three quality of life instruments in subjects with angina pectoris: the Sickness Impact Profile, the Nottingham Health Profile, and the Quality of Well Being Scale. J Clin Epidemiol (1994) 1.05
The relationship between a low treated blood pressure and IHD mortality: a report from the DHSS Hypertension Care Computing Project (DHCCP). J Hum Hypertens (1988) 1.03
Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension. Lancet (1979) 1.02
The diurnal blood pressure profile. A population study. Am J Hypertens (1992) 1.02
Endothelial cell loss and corneal thickness after intracapsular extraction and iris clip lens implantation: a randomised controlled trial (interim report). Br J Ophthalmol (1977) 1.01
Incidence of diabetes and gout in hypertensive patients during 8 years of follow-up. The General Practice Hypertension Study Group. J Hum Hypertens (1997) 1.01
Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens (1990) 1.01
Evaluation of quality of life in clinical trials of cardiovascular disease. J Chronic Dis (1987) 1.00
Cancer mortality and atenolol treatment. BMJ (1993) 1.00
The symptoms of patients treated for Parkinson's disease. Clin Neuropharmacol (1985) 0.99
Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch Intern Med (1998) 0.99
Contribution of environmental factors to variability in human drug metabolism. Drug Metab Rev (1979) 0.99
Environmental effects on antipyrine half-life in man. Clin Pharmacol Ther (1977) 0.99
Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol. Br Med J (Clin Res Ed) (1982) 0.99
Prevalence of venous disease: a community study in west London. Eur J Surg (1992) 0.97
Hypertension caused by low-level lead exposure: myth or fact? J Cardiovasc Risk (1994) 0.97
The relationship between blood pressure and biochemical risk factors in a general population. Br J Prev Soc Med (1976) 0.97
Familial aggregation of blood pressure, anthropometric characteristics and urinary excretion of sodium and potassium--a population study in two Belgian towns. J Chronic Dis (1985) 0.96
Velocity profiles in the retinal microcirculation. Bibl Anat (1973) 0.96
The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP). J Hypertens (1986) 0.95
Cough with angiotensin converting enzyme inhibitors: how much of a problem? J Hypertens Suppl (1994) 0.94
The effects of verapamil and propranolol on quality of life in hypertension. J Hum Hypertens (1989) 0.94
Blood lead concentration, renal function, and blood pressure in London civil servants. Br J Ind Med (1990) 0.94
Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension. Hypertension (1998) 0.92
A questionnaire to assess risk factors, quality of life, and use of health resources in patients with venous disease. Eur J Surg (1992) 0.92
Antipyrene clearance in Indian villagers. Br J Clin Pharmacol (1980) 0.92
Blood pressure, the prevalence of cardiovascular diseases, and exposure to cadmium: a population study. Am J Epidemiol (1991) 0.92
Serum uric acid in hypertensive patients. Br Heart J (1975) 0.91
Quality of life on angina therapy. Lancet (1988) 0.91
Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. Invest Ophthalmol (1969) 0.90
Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis. Br J Clin Pharmacol (1976) 0.90
Estimation of retinal blood flow by measurement of the mean circulation time. Cardiovasc Res (1971) 0.89
Effects of papaverine on the retinal microcirculation. Br J Ophthalmol (1973) 0.89
Acute phase proteins, C-reactive protein and serum amyloid A protein, as prognostic markers in the elderly inpatient. Age Ageing (1997) 0.89
Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial. Br Med J (Clin Res Ed) (1984) 0.88